Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovary-specific spectral library.

Qian, Liujia; Zhu, Jianqing; Xue, Zhangzhi; Gong, Tingting; Xiang, Nan; Yue, Liang; Cai, Xue; Gong, Wangang; Wang, Junjian; Sun, Rui; Jiang, Wenhao; Ge, Weigang; Wang, He; Zheng, Zhiguo; Wu, Qijun; Zhu, Yi; Guo, Tiannan

Qian, Liujia; Zhu, Jianqing; Xue, Zhangzhi; Gong, Tingting; Xiang, Nan; Yue, Liang; Cai, Xue; Gong, Wangang; Wang, Junjian; Sun, Rui; Jiang, Wenhao; Ge, Weigang; Wang, He; Zheng, Zhiguo; Wu, Qijun; Zhu, Yi; Guo, Tiannan.

Afiliação

Qian L; School of Medicine, Zhejiang University, Hangzhou, China.
Zhu J; Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Xue Z; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China.
Gong T; The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Xiang N; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Yue L; Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Cai X; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China.
Gong W; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Wang J; Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Sun R; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China.
Jiang W; Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Ge W; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China.
Wang H; Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Zheng Z; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China.
Wu Q; The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Zhu Y; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Guo T; The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.

Mol Oncol ; 17(8): 1567-1580, 2023 08.

Article em En | MEDLINE | ID: mdl-36855266

Assuntos

Terapia Neoadjuvante; Neoplasias Ovarianas; Feminino; Humanos; Proteômica; Quimioterapia Adjuvante; Neoplasias Ovarianas/patologia; Estadiamento de Neoplasias; Estudos Retrospectivos

Palavras-chave

MS spectral library; chemotherapy resistance; data-independent acquisition; machine learning; ovarian cancer; targeted proteomics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google